Posted on December 02nd, 2009 in Franklin Templeton, India Shares, Pharmaceutical Sector, Sun Pharmaceutical
Pharmaceutical major Sun Pharmaceutical has finally got some relief after Franklin Templeton has finally decided to withdraw the appeal against the company. Franklin Templeton was a co- appellant along with Israeli pharmaceutical major Taro Pharma against Sun Pharma.
The news helped the shares of Sun Pharma to upsurge by 5.62% to Rs. 1538.80 on the BSE.
Tags: India Share market, India Shares


